Development of Simultaneous Detection of Total Prostate-Specific Antigen (tPSA) and Free PSA With Rapid Bead-Based Immunoassay

被引:20
作者
Xie, Chong [1 ]
Wang, Guomin [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China
关键词
tumor marker; luminex assay; prostate cancer; prostate-specific antigen; simultaneous detection; CANCER DETECTION; COMPLEXED PSA; ASSAYS; FORMS; ALPHA-1-ANTICHYMOTRYPSIN; DISEASE; BENIGN; TRIAL; NG/ML; RATIO;
D O I
10.1002/jcla.20427
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: Prostate-specific antigen (PSA) is the most important biochemical tumor marker for the early detection of prostate cancer; however, its diagnostic specificity is low. Therefore, free PSA (fPSA) test is recommended as an adjunct to increase the specificity. However, all the current technology only allows detecting one biomarker at one time. In this study, we reported a flexible bead-based immunoassay to measure total PSA (tPSA) and fPSA simultaneously. Materials and Methods: We used the Luminex xMAP bead array technology to measure tPSA and fPSA at one time, employing two mouse monoclonal anti-PSA antibodies (5G6 and 8A6) for coating and another mouse monoclonal anti-PSA antibody (5A6) for detection. Then we compared the data of Luminex assay with that of the conventional enzyme-linked immunosorbent assay (ELISA). Results The assay was fast with a wide dynamic range. The lower detection limit for tPSA and fPSA were 2.3 and 1.3 pg/ml. The inter-assay coefficients for tPSA and fPSA were between 5.64 and 7.65%, and the intra-assay coefficients for tPSA and fPSA were between 4.15 and 5.89%. A close correlation between the new assay and the conventional ELISA was observed. Conclusions The bead-based platform is rapid, sensitive, and less expensive, which allows both single sample and high-throughput measurement of tPSA and fPSA over a wide range of concentrations. J. Clin. Lab. Anal. 25:37-42, 2011. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 50 条
[21]   Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values [J].
Yilmaz, Hasan ;
Ciftci, Seyfettin ;
Yavuz, Ufuk ;
Ustuner, Murat ;
Saribacak, Ali ;
Dillioglugil, Ozdal .
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2015, 31 (06) :315-319
[22]   Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels [J].
Recker, F ;
Kwiatkowski, MK ;
Piironen, T ;
Pettersson, K ;
Goepel, M ;
Tscholl, R .
BRITISH JOURNAL OF UROLOGY, 1998, 81 (04) :532-538
[23]   Multiple optical trapping assisted bead-array based fluorescence assay of free and total prostate-specific antigen in serum [J].
Cao, Di ;
Li, Cheng-Yu ;
Qi, Chu-Bo ;
Chen, Hong-Lei ;
Pang, Dai-Wen ;
Tang, Hong-Wu .
SENSORS AND ACTUATORS B-CHEMICAL, 2018, 269 :143-150
[24]   Free/total prostate-specific antigen ratio - Hope and controversies [J].
Ravery, V ;
BocconGibod, L .
EUROPEAN UROLOGY, 1997, 31 (04) :385-388
[25]   Levels of free prostate-specific antigen (PSA) can be selectively measured by heat treatment of serum: free/total-PSA ratios improve detection of prostate carcinoma [J].
Yoshida, K ;
Honda, M ;
Sumi, S ;
Arai, K ;
Suzuki, S ;
Kitahara, S .
CLINICA CHIMICA ACTA, 1999, 280 (1-2) :195-203
[26]   Dual monoclonal antibody immunoassay for free prostate-specific antigen [J].
Wang, TJ ;
Hill, TM ;
Sokoloff, RL ;
Frankenne, F ;
Rittenhouse, HG ;
Wolfert, RL .
PROSTATE, 1996, 28 (01) :10-16
[27]   Activity does not affect free and total prostate-specific antigen levels but lowers the free-to-total prostate-specific antigen ratio [J].
Ulman, C ;
Buyukyazi, G ;
Taneli, F ;
Uyanik, BS .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (06) :583-589
[28]   Classifying prostate cancer patients based on total prostate-specific antigen and free prostate-specific antigen features by support vector machine [J].
Nguyen Thi Hong Nhung ;
Vu Tran Minh Khuong ;
Vu Quang Huy ;
Pham The Bao .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) :818-825
[29]   Stability of total prostate-specific antigen and free prostate-specific antigen after 10 years' storage [J].
Simanek, Vaclav ;
Topolcan, Ondrej ;
Karlikova, Marie ;
Dolejsova, Olga ;
Fuchsova, Radka ;
Kinkorova, Judita ;
Slouka, David ;
Kucera, Radek .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (04) :463-466
[30]   The Clinical Importance of Percentage Free Prostate-specific Antigen (PSA) in the PSA level of 4-20 ng/ml [J].
Caliskan, Selahattin ;
Sungur, Mustafa .
KUWAIT MEDICAL JOURNAL, 2018, 50 (03) :316-319